Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001882764-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
10,000
Total Value
$295,839.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Mar 6, 2026 | Sale | 10,000 | $29.58 | $295,839.00 | 51,000 | Direct | โ | View Details |